Noble Financial analyst Joe Gomes maintained a Buy rating on Medicine Man Technologies (SHWZ – Research Report) today and set a price target of $4.00. The company’s shares closed yesterday at $0.52.
Gomes covers the Industrials sector, focusing on stocks such as Orion Group Holdings, Geo Group, and DLH Holdings. According to TipRanks, Gomes has an average return of 6.0% and a 43.58% success rate on recommended stocks.
Medicine Man Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $3.25, which is a 525.00% upside from current levels. In a report released yesterday, Benchmark Co. also maintained a Buy rating on the stock with a $2.50 price target.
SHWZ market cap is currently $40.69M and has a P/E ratio of -0.61.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medicine Man Technologies (SHWZ) Company Description:
Medicine Man Technologies, Inc. engages in the cultivation, marketing, and distribution of medical and recreational cannabis. It provides supply chain, cultivation, dispensary, processing, and feasibility consulting. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.
